Handout 1: Medical summary

Food Insecurity and the Dangers of Infant Formula Dilution

Tyra Bryant-Stephens, MD, encourages families to revisit asthma triggers, refill medications, and manage allergies to prevent avoidable complications.

January 30th 2023

HHS to remove thimerosal from all influenza vaccines in the US

Demystifying Infant Formula

Secretary Robert F. Kennedy, Jr. this week signed the ACIP's recommendation to remove the mercury-based preservative from all influenza vaccines.

October 11th 2022

FDA grants fast track designation to SGT-501 gene therapy for CPVT

Nirsevimab demonstrates high effectiveness against RSV in healthy term infants

Solid Biosciences is planning a phase 1b clinical trial of SGT-501 to treat the catecholaminergic polymorphic ventricular tachycardia heart condition.

Morgan Ebert, Managing Editor

Tyra Bryant-Stephens, MD, talks asthma reminders ahead of school year

Nirsevimab reduced RSV-related illness by up to 98% and lowered hospitalizations and health care use among healthy term infants in a real-world study.

Related Content

Tyra Bryant-Stephens, MD

Food Insecurity and the Dangers of Infant Formula Dilution

Tyra Bryant-Stephens, MD, encourages families to revisit asthma triggers, refill medications, and manage allergies to prevent avoidable complications.

January 30th 2023

HHS to remove thimerosal from all influenza vaccines in the US

Demystifying Infant Formula

Secretary Robert F. Kennedy, Jr. this week signed the ACIP's recommendation to remove the mercury-based preservative from all influenza vaccines.

October 11th 2022

FDA grants fast track designation to SGT-501 gene therapy for CPVT

Nirsevimab demonstrates high effectiveness against RSV in healthy term infants

Solid Biosciences is planning a phase 1b clinical trial of SGT-501 to treat the catecholaminergic polymorphic ventricular tachycardia heart condition.

Morgan Ebert, Managing Editor